Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 5 Results

Intervention Indication Therapeutic Area Year Actions
Afamitresgene autoleucel for advanced synovial sarcoma or myxoid/round cell liposarcoma ADP-A2M4 (MAGE-A4 SPEAR T-cell) Soft tissue sarcoma , Synovial sarcoma Sarcoma 2021 View  |  Download
Carotuximab in combination with Pazopanib for Advanced Angiosarcoma Carotuximab (TRC105; DE-122) , Pazopanib (Votrient; GW 786034; pazopanib hydrochloride) Soft tissue sarcoma Sarcoma 2018 View  |  Download
NY-ESO-1 T cells for the treatment of synovial sarcoma NY-ESO-1c259-modified SPEAR T Cells (GSK3377794) Soft tissue sarcoma Sarcoma 2017 View  |  Download
Onfekafusp alfa in addition to doxorubicin for advanced or metastatic soft tissue sarcoma – first line Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Onfekafusp alfa (L19-TNF; Fibromun) Soft tissue sarcoma Sarcoma 2019 View  |  Download
Selinexor for advanced unresectable dedifferentiated liposarcoma Selinexor (KPT-330; Xpovio) Soft tissue sarcoma Sarcoma 2020 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications